These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8108804)

  • 1. [The treatment of histiocytosis X (Langerhans-cell histiocytosis) with alpha-interferon preparations].
    Lukina EA; Kuznetsov VP; Beliaev DL; Kaplanskaia IB; Mokeeva RA
    Ter Arkh; 1993; 65(11):67-70. PubMed ID: 8108804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with interferon of systemic Langerhans-cell histiocytosis in an adult].
    Albanell J; Salud A; Bellmunt J; Español T; Morales S; García-Bragado F; Solé-Calvo LA
    Med Clin (Barc); 1990 Feb; 94(5):184-6. PubMed ID: 2325479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histiocytosis X: successful treatment with recombinant interferon-alpha A.
    Sato Y; Ikeda Y; Ito E; Miyano T; Kawauchi K; Yokoyama M; Kamata Y
    Acta Paediatr Jpn; 1990 Apr; 32(2):151-4. PubMed ID: 2116063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of different forms of B and delta hepatitis with interferon preparations].
    Botsvadze ESh; Kuznetsov VP; Aleksishvili MM; Gogichaĭshvili ShSh
    Ter Arkh; 1991; 63(11):61-3. PubMed ID: 1810067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread skin-limited adult Langerhans cell histiocytosis: long-term follow-up with good response to interferon alpha.
    Chang SE; Koh GJ; Choi JH; Lee KH; Sung KJ; Moon KC; Koh JK
    Clin Exp Dermatol; 2002 Mar; 27(2):135-7. PubMed ID: 11952707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated Langerhans cell histiocytosis in identical twins unresponsive to recombinant human alpha-interferon and total body irradiation.
    Halton J; Whitton A; Wiernikowski J; Barr RD
    Am J Pediatr Hematol Oncol; 1992 Aug; 14(3):269-72. PubMed ID: 1510199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon and disseminated Langerhans cell histiocytosis.
    Bellmunt J; Albanell J; Salud A; Español T; Morales S; Solé-Calvo LA
    Med Pediatr Oncol; 1992; 20(4):336-7. PubMed ID: 1608357
    [No Abstract]   [Full Text] [Related]  

  • 8. Widespread skin-limited Langerhans cell histiocytosis: complete remission with interferon alfa.
    Kwong YL; Chan AC; Chan TK
    J Am Acad Dermatol; 1997 Apr; 36(4):628-9. PubMed ID: 9092752
    [No Abstract]   [Full Text] [Related]  

  • 9. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC.
    Culić S; Jakobson A; Culić V; Kuzmić I; Sćukanec-Spoljar M; Primorac D
    Pediatr Hematol Oncol; 2001 Jun; 18(4):291-4. PubMed ID: 11400655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of severe forms of Langerhans cell histiocytosis].
    Bertrand Y
    Pediatrie; 1993; 48(11):770-4. PubMed ID: 8058434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Langerhans cell histiocytosis with alpha-interferon.
    Jakobson AM; Kreuger A; Hagberg H; Sundström C
    Lancet; 1987 Dec; 2(8574):1520-1. PubMed ID: 2892073
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
    Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
    J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha therapy, protein kinase C-alpha and Langerhans cell histiocytosis.
    Brown RE
    Med Pediatr Oncol; 2003 Jul; 41(1):63-4. PubMed ID: 12764746
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
    Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
    Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial using thalidomide for Langerhans cell histiocytosis.
    McClain KL; Kozinetz CA
    Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic prospects of interferon in patients with chronic myelocytic leukemia].
    Podsiadło Z; Skotnicki AB; Blicharski J
    Przegl Lek; 1988; 45(9):687-9. PubMed ID: 3075051
    [No Abstract]   [Full Text] [Related]  

  • 17. Resolution of cutaneous lesions of histiocytosis X by intralesional injections of interferon beta.
    Matsushima Y; Baba T
    Int J Dermatol; 1991 May; 30(5):373-4. PubMed ID: 2066198
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of alpha interferon preparations in acute lymphoblastic leukemia in children during remission].
    Gavrilova IE; Kuznetsov IP; Denisov LA; Maiakova SA; Orlova TG; Kadagidze ZG; Makhonova LA
    Pediatriia; 1991; (11):75-8. PubMed ID: 1766748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].
    Bernengo MG; Doveil GC; Appino A; Sertoli MR; Ardizzoni A; Vidili MG
    G Ital Dermatol Venereol; 1988 Apr; 123(4):185-8. PubMed ID: 3182009
    [No Abstract]   [Full Text] [Related]  

  • 20. Langerhans cell histiocytosis of spine: a comparative study of clinical, imaging features, and diagnosis in children, adolescents, and adults.
    Huang WD; Yang XH; Wu ZP; Huang Q; Xiao JR; Yang MS; Zhou ZH; Yan WJ; Song DW; Liu TL; Jia NY
    Spine J; 2013 Sep; 13(9):1108-17. PubMed ID: 23602327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.